The Campaign Against Drug Pricing: Candidates Can Only Hope Voters React As Strongly As Wall Street
This article was originally published in RPM Report
Executive Summary
Wall Street remains hypersensitive to threats from Washington or the campaign trail to take action to limit prescription drug pricing. But it is still hard to see why the threat is any greater because the Clinton campaign has a “plan” to address the issue.
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
